Stock of Eli Lilly (NYSE: LLY), the famed Indianapolis pharmaceuticals giant, jumped 8.3% through 12:45 p.m. ET after the company reported a massive earnings beat this morning.

Heading into the quarter, Wall Street analysts forecast Lilly would earn $2.60 per share on sales of $9.9 billion. Instead, Lilly reported a blockbuster $3.92-per-share profit, and sales of $11.3 billion.

How did Lilly do that? Three words: Mounjaro, Zepbound, and... Verzenio.

Continue reading

Source Fool.com